OS | PFS | AML transformation | |||||||
---|---|---|---|---|---|---|---|---|---|
HR | 95 % CI | P | HR | 95 % CI | P | HR | 95 % CI | P | |
Age (>60 years vs. ≤ 60 years) | 0.964 | 0.374–2.487 | 0.940 | 1.295 | 0.516–3.252 | 0.581 | 0.924 | 0.290–2.945 | 0.893 |
IPSS-R risk groupsb, higher vs. lower | 5.600 | 1.453–21.583 | 0.010 | 5.864 | 1.186–28.982 | 0.023 | |||
SF3B1c (mut vs. WT) | 1.347 | 0.261–6.947 | 0.662 | 0.452 | 0.054–3.779 | 0.684 | |||
U2AF1 (mut vs. WT) | 1.167 | 0.231–5.893 | 1.000 | 4.409 | 1.174–16.558 | 0.033 | 0.906 | 0.106–7.737 | 1.000 |
SRSF2 (mut vs. WT) | 0.823 | 0.170–3.989 | 1.000 | 3.878 | 1.181–12.726 | 0.018 | 2.864 | 0.684–11.989 | 0.151 |